YBX1作为T细胞急性淋巴细胞白血病的致癌因子
研究发现YBX1在T-ALL患者、T-ALL细胞系及NOTCH1诱导的T-ALL小鼠中表达上调;体外敲低YBX1可降低细胞增殖、诱导凋亡及G0/G1期阻滞,体内敲低可显著减轻人T-ALL异种移植和NOTCH1诱导T-ALL小鼠的白血病负荷;机制上YBX1下调抑制AKT、p-AKT、ERK及p-ERK表达。
要点
- YBX1在T-ALL患者、T-ALL细胞系及NOTCH1诱导的T-ALL小鼠中表达上调。
- 敲低YBX1在体外降低T-ALL细胞增殖、诱导凋亡和G0/G1期阻滞。
- 敲低YBX1在体内显著减轻人T-ALL异种移植和NOTCH1诱导T-ALL小鼠的白血病负荷。
核心结论
- YBX1在T-ALL的白血病发生中起关键作用,可能作为T-ALL的生物标志物和治疗靶点。
研究设计与样本
- 研究检测了T-ALL患者、T-ALL细胞系和NOTCH1诱导的T-ALL小鼠中YBX1的表达,并在体外和体内进行YBX1敲低实验。
主要发现
- YBX1在T-ALL患者、T-ALL细胞系及NOTCH1诱导的T-ALL小鼠中表达上调。
- 体外敲低YBX1显著降低细胞增殖、诱导细胞凋亡并诱导G0/G1期阻滞。
- 体内敲低YBX1显著减轻人T-ALL异种移植和NOTCH1诱导T-ALL小鼠模型的白血病负荷。
- 敲低YBX1显著抑制T-ALL细胞中总AKT、p-AKT、总ERK及p-ERK的表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Y-box-binding protein 1 (YBX1), a member of the RNA-binding protein family, is a critical regulator of cell survival in various solid tumors and acute myeloid leukemia. However, the function of YBX1 in T-cell acute lymphoblastic leukemia (T-ALL) remains elusive. Here, we found that YBX1 was upregulated in patients with T-ALL, T-ALL cell lines, and NOTCH1-induced T-ALL mice. Furthermore, depletion of YBX1 dramatically reduced cell proliferation, induced cell apoptosis, and induced G0/G1 phase arrest in vitro. Moreover, YBX1 depletion significantly decreased the leukemia burden in the human T-ALL xenograft and NOTCH1-induced T-ALL mice model in vivo. Mechanistically, downregulation of YBX1 markedly inhibited the expression of total AKT serine/threonine kinase (AKT), p-AKT, total extracellular signal-regulated kinase (ERK), and p-ERK in T-ALL cells. Taken together, our results uncovered a critical role of YBX1 in the leukemogenesis of T-ALL, which may have great potential as a biomarker and therapeutic target in T-ALL.
引用
- Li H, Zhang D, Fu Q, et al. YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia. Blood Adv. 2023. PMID: 37339496. doi:10.1182/bloodadvances.2022009648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。